Literature DB >> 2850456

Postsynaptic gamma-aminobutyric acid receptors in hepatic coma following portacaval shunt and hepatic artery ligation in the rat.

P Ferenci1, L Zieve, J Ebner, C Zimmermann, D Rzepczynski.   

Abstract

The specific binding of gamma-aminobutyric acid (GABA) to synaptic membranes prepared from the brains of rats with acute liver failure due to portacaval shunt and hepatic artery ligation was measured. No changes in the affinity or the density of the low- and high-affinity binding sites of the GABA receptor were observed, indicating that this model of acute hepatic encephalopathy is apparently not associated with altered GABAergic neurotransmission.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2850456     DOI: 10.1007/bf00999610

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  12 in total

1.  Brain gamma-aminobutyric acid receptor binding is normal in rats with thioacetamide-induced hepatic encephalopathy despite elevated plasma gamma-aminobutyric acid-like activity.

Authors:  J E Maddison; P R Dodd; G A Johnston; G C Farrell
Journal:  Gastroenterology       Date:  1987-11       Impact factor: 22.682

2.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

3.  Experimental hepatic encephalopathy: changes in the binding of gamma-aminobutyric acid.

Authors:  M Baraldi; Z L Zeneroli
Journal:  Science       Date:  1982-04-23       Impact factor: 47.728

4.  Hepatic encephalopathy and the gamma-aminobutyric-acid neurotransmitter system.

Authors:  D F Schafer; E A Jones
Journal:  Lancet       Date:  1982-01-02       Impact factor: 79.321

5.  Supersensitivity of benzodiazepine receptors in hepatic encephalopathy due to fulminant hepatic failure in the rat: reversal by a benzodiazepine antagonist.

Authors:  M Baraldi; M L Zeneroli; E Ventura; A Penne; G Pinelli; P Ricci; M Santi
Journal:  Clin Sci (Lond)       Date:  1984-08       Impact factor: 6.124

6.  Visual evoked potentials in a rabbit model of hepatic encephalopathy. I. Sequential changes and comparisons with drug-induced comas.

Authors:  D F Schafer; S C Pappas; L E Brody; R Jacobs; E A Jones
Journal:  Gastroenterology       Date:  1984-03       Impact factor: 22.682

7.  Gamma-aminobutyric acid binding to receptor sites in the rat central nervous system.

Authors:  S R Zukin; A B Young; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

8.  Brain edema in rabbits with galactosamine-induced fulminant hepatitis. Regional differences and effects on intracranial pressure.

Authors:  P G Traber; D R Ganger; A T Blei
Journal:  Gastroenterology       Date:  1986-12       Impact factor: 22.682

9.  In vivo studies of GABAergic effects in experimental hepatic encephalopathy.

Authors:  D Rzepczynski; L Zieve; S Lindblad; D LaFontaine
Journal:  Hepatology       Date:  1986 Sep-Oct       Impact factor: 17.425

10.  A model of fulminant hepatic failure in the rabbit.

Authors:  B L Blitzer; J G Waggoner; E A Jones; H R Gralnick; D Towne; J Butler; V Weise; I J Kopin; I Walters; P F Teychenne; D G Goodman; P D Berk
Journal:  Gastroenterology       Date:  1978-04       Impact factor: 22.682

View more
  2 in total

1.  Flumazenil does not improve hepatic encephalopathy associated with acute ischemic liver failure in the rabbit.

Authors:  C C van der Rijt; R J de Knegt; S W Schalm; O T Terpstra; K Mechelse
Journal:  Metab Brain Dis       Date:  1990-09       Impact factor: 3.584

2.  A benzodiazepine antagonist does not alter the course of hepatic encephalopathy or neural gamma-aminobutyric acid (GABA) binding.

Authors:  L Zieve; P Ferenci; D Rzepczynski; J Ebner; C Zimmermann
Journal:  Metab Brain Dis       Date:  1987-09       Impact factor: 3.584

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.